The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2
Abstract
LSD1 and LSD2 histone demethylases are implicated in a number of physiological and pathological processes, ranging from tumorigenesis to herpes virus infection. A comprehensive structural, biochemical, and cellular study is presented here to probe the potential of these enzymes for epigenetic therapies. This approach employs tranylcypromine as a chemical scaffold for the design of novel demethylase inhibitors. This drug is a clinically validated antidepressant known to target monoamine oxidases A and B. These two flavoenzymes are structurally related to LSD1 and LSD2. Mechanistic and crystallographic studies of tranylcypromine inhibition reveal a lack of selectivity and differing covalent modifications of the FAD cofactor depending on the enantiomeric form. These findings are pharmacologically relevant, since tranylcypromine is currently administered as a racemic mixture. A large set of tranylcypromine analogues were synthesized and screened for inhibitory activities. We found that the common evolutionary origin of LSD and MAO enzymes, despite their unrelated functions and substrate specificities, is reflected in related ligand-binding properties. A few compounds with partial enzyme selectivity were identified. The biological activity of one of these new inhibitors was evaluated with a cellular model of acute promyelocytic leukemia chosen since its pathogenesis includes aberrant activities of several chromatin modifiers. Marked effects on cell differentiation and an unprecedented synergistic activity with antileukemia drugs were observed. These data demonstrate that these LSD1/2 inhibitors are of potential relevance for the treatment of promyelocytic leukemia and, more generally, as tools to alter chromatin state with promise of a block of tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation
Lee, M. G., Wynder, C., Cooch, N., & Shiekhattar, R. (2005) · Nature · doi:10.1038/nature04021 · Cited by 802
Di Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Coco, F. L., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 787
Self-citationCovalent modifications of histones during development and disease pathogenesis
Bhaumik, S. R., Smith, E., & Shilatifard, A. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1337 · Cited by 681
Son, S.-Y., Ma, J., Kondou, Y., Yoshimura, M., Yamashita, E., & Tsukihara, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710626105 · Cited by 623
De Colibus, L., Li, M., Binda, C., Lustig, A., Edmondson, D. E., & Mattevi, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505975102 · Cited by 527
Self-citationKDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints
Ciccone, D. N., Su, H., Hevi, S., Gay, F., Lei, H., Bajko, J., Xu, G., Li, E., & Chen, T. (2009) · Nature · doi:10.1038/nature08315 · Cited by 514
Schulte, J. H., Lim, S., Schramm, A., Friedrichs, N., Koster, J., Versteeg, R., Ora, I., Pajtler, K., Klein-Hitpass, L., Kuhfittig-Kulle, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1735 · Cited by 445
Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive Medications
Lee, M. G., Wynder, C., Schmidt, D. M., McCafferty, D. G., & Shiekhattar, R. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.004 · Cited by 438
Binda, C., Li, M., Hubálek, F., Restelli, N., Edmondson, D. E., & Mattevi, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633804100 · Cited by 397
Self-citationtrans-2-Phenylcyclopropylamine Is a Mechanism-Based Inactivator of the Histone Demethylase LSD1
Schmidt, D. M. Z., & McCafferty, D. G. (2007) · Biochemistry · doi:10.1021/bi0618621 · Cited by 307
Molecular and Mechanistic Properties of the Membrane-Bound Mitochondrial Monoamine Oxidases
Edmondson, D. E., Binda, C., Wang, J., Upadhyay, A. K., & Mattevi, A. (2009) · Biochemistry · doi:10.1021/bi900413g · Cited by 300
Self-citationA Novel Mammalian Flavin-dependent Histone Demethylase
Karytinos, A., Forneris, F., Profumo, A., Ciossani, G., Battaglioli, E., Binda, C., & Mattevi, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003087 · Cited by 273
Self-citationStructural Basis of LSD1-CoREST Selectivity in Histone H3 Recognition
Forneris, F., Binda, C., Adamo, A., Battaglioli, E., & Mattevi, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700100200 · Cited by 235
Self-citationYang, M., Culhane, J. C., Szewczuk, L. M., Jalili, P., Ball, H. L., Machius, M., Cole, P. A., & Yu, H. (2007) · Biochemistry · doi:10.1021/bi700664y · Cited by 234
Identification of Cell-Active Lysine Specific Demethylase 1-Selective Inhibitors
Ueda, R., Suzuki, T., Mino, K., Tsumoto, H., Nakagawa, H., Hasegawa, M., Sasaki, R., Mizukami, T., & Miyata, N. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907055q · Cited by 189
Structural basis of histone demethylation by LSD1 revealed by suicide inactivation
Yang, M., Culhane, J. C., Szewczuk, L. M., Gocke, C. B., Brautigam, C. A., Tomchick, D. R., Machius, M., Cole, P. A., & Yu, H. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1255 · Cited by 178
LSD1: oxidative chemistry for multifaceted functions in chromatin regulation
Forneris, F., Binda, C., Battaglioli, E., & Mattevi, A. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.01.003 · Cited by 165
Self-citationStructure and Mechanism of Lysine-specific Demethylase Enzymes
Anand, R., & Marmorstein, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700027200 · Cited by 157
Culhane, J. C., Wang, D., Yen, P. M., & Cole, P. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909996p · Cited by 154
Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 Å
Mimasu, S., Sengoku, T., Fukuzawa, S., Umehara, T., & Yokoyama, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.066 · Cited by 137
LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis
Hu, X., Li, X., Valverde, K., Fu, X., Noguchi, C. T., Qiu, Y., & Huang, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900437106 · Cited by 121
Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer
Botrugno, O. A., Santoro, F., & Minucci, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.027 · Cited by 105
Self-citationMinucci, S., Monestiroli, S., Giavara, S., Ronzoni, S., Marchesi, F., Insinga, A., Diverio, D., Gasparini, P., Capillo, M., Colombo, E., et al. (2002) · Blood · doi:10.1182/blood-2001-11-0089 · Cited by 100
Self-citationSilverman, R. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43725-2 · Cited by 92
Walker, W. H., Hemmerich, P. H., & Massey, V. (1967) · Helvetica Chimica Acta · doi:10.1002/hlca.19670500812 · Cited by 75
AOF1 is a histone H3K4 demethylase possessing demethylase activity-independent repression function
Yang, Z., Jiang, J., Stewart, M. D., Qi, S., Yamane, K., Li, J., Zhang, Y., & Wong, J. (2010) · Cell Research · doi:10.1038/cr.2010.12 · Cited by 74
New method to detect histone acetylation levels by flow cytometry
Ronzoni, S., Faretta, M., Ballarini, M., Pelicci, P. G., & Minucci, S. (2005) · Cytometry Part A · doi:10.1002/cyto.a.20151 · Cited by 66
Self-citationEngagement of the Lysine-Specific Demethylase/HDAC1/CoREST/REST Complex by Herpes Simplex Virus 1
Gu, H., & Roizman, B. (2009) · Journal of Virology · doi:10.1128/jvi.02515-08 · Cited by 55
Epigenetic opportunities and challenges in cancer
Best, J. D., & Carey, N. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.010 · Cited by 49
Structural Comparison of Human Monoamine Oxidases A and B
Hubálek, F., Pohl, J., & Edmondson, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303712200 · Cited by 46
Self-citation
Cited by
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Schenk, T., Chen, W. C., Göllner, S., Howell, L., Jin, L., Hebestreit, K., Klein, H.-U., Popescu, A. C., Burnett, A., Mills, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2661 · Cited by 672
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
Mohammad, H. P., Smitheman, K. N., Kamat, C. D., Soong, D., Federowicz, K. E., Van Aller, G. S., Schneck, J. L., Carson, J. D., Liu, Y., Butticello, M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.06.002 · Cited by 504
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Fang, Y., Liao, G., & Yu, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0811-9 · Cited by 438
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
Morera, L., Lübbert, M., & Jung, M. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0223-4 · Cited by 395
Metadata
- Authors
- Binda, C., Valente, S., Romanenghi, M., Pilotto, S., Cirilli, R., Karytinos, A., Ciossani, G., Botrugno, O. A., Forneris, F., Tardugno, M., Edmondson, D. E., Minucci, S., Mattevi, A., & Mai, A.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-04-23
- Volume
- 132
- Issue
- 19
- Pages
- 6827-6833
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2130996711
- Cited by
- 284
- References
- 31
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.